non-small cell lung cancer

AdventRx: Safe Biotech With Upcoming Catalysts That May Boost It More
Seeking Alpha
Tue, 02/15/11 - 11:55 am
Adventrx
Exelbine
non-small cell lung cancer
Oncothyreon announces that Merck Serono is resuming the Stimuvax clinical program in lung cancer
Yahoo/PR NewsWire
Thu, 06/17/10 - 09:19 am
Oncothyreon
Merck Serono
Stimuvax
non-small cell lung cancer
Researchers Report Treatment Headway Against Lung Cancer
BusinessWeek
Sun, 06/6/10 - 11:52 am
crizotinib
non-small cell lung cancer
Pfizer
OXiGENE Reports Encouraging Safety and Efficacy Data from Ongoing Phase 2 Trial of ZYBRESTAT in Non-Small Cell Lung Cancer at the 2010 ASCO Annual Meeting
Yahoo/Globe NewsWire
Sun, 06/6/10 - 10:53 am
Oxigene
non-small cell lung cancer
Zybrestat
Results of Phase 3 ABRAXANE® Combination Trial In First-Line Non-Small Cell Lung Cancer Show 31 Percent Improvement In Response Rate Compared With Taxol Combination
BusinessWire
Sat, 06/5/10 - 12:34 pm
Abraxane
Taxol
carboplatin
companies
non-small cell lung cancer
Exelixis Presents Positive Data
Yahoo/Zacks
Sat, 05/22/10 - 09:38 am
XL184
Bristol-Myers Squibb
glioblastoma
brain cancer
melanoma
non-small cell lung cancer
small cell lung cancer
hepatocellular carcinoma
pancreatic
gastric
prostate
ovarian
breast cancer
Hope Grows for FDA Approval of Adventrix's Chemo Drug
Seeking Alpha
Sun, 05/2/10 - 11:15 am
Adventrx
ANX-53
vinorelbine. Navelbine
non-small cell lung cancer
FDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
Yahoo/BusinessWire
Sat, 04/17/10 - 12:23 pm
Tarceva
OSI Pharmaceuticals
non-small cell lung cancer
SATURN
Pfizer Fails… Again
Minyanville
Sat, 03/13/10 - 10:03 am
Sutent
non-small cell lung cancer
Pfizer
figitumumab
breast cancer
Zactima’s FDA Application withdrawn (NASDAQ:AZN)
favstocks.com
Sun, 01/31/10 - 11:20 am
Zactima
AstraZeneca
non-small cell lung cancer
lung cancer

Pages